- Home
- NEOV vs TVGN Comparison
NEOV vs TVGN Comparison
Compare NEOV & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- TVGN
- Stock Information
- Founded
- NEOV 2018
- TVGN 2020
- Country
- NEOV United States
- TVGN United States
- Employees
- NEOV N/A
- TVGN N/A
- Industry
- NEOV Industrial Machinery/Components
- TVGN Blank Checks
- Sector
- NEOV Miscellaneous
- TVGN Finance
- Exchange
- NEOV Nasdaq
- TVGN Nasdaq
- Market Cap
- NEOV 72.2M
- TVGN 193.1M
- IPO Year
- NEOV N/A
- TVGN N/A
- Fundamental
- Price
- NEOV $4.54
- TVGN $1.21
- Analyst Decision
- NEOV Strong Buy
- TVGN Strong Buy
- Analyst Count
- NEOV 1
- TVGN 1
- Target Price
- NEOV $7.50
- TVGN $10.00
- AVG Volume (30 Days)
- NEOV 177.8K
- TVGN 422.7K
- Earning Date
- NEOV 05-09-2025
- TVGN 08-13-2025
- Dividend Yield
- NEOV N/A
- TVGN N/A
- EPS Growth
- NEOV N/A
- TVGN N/A
- EPS
- NEOV N/A
- TVGN N/A
- Revenue
- NEOV $4,255,136.00
- TVGN N/A
- Revenue This Year
- NEOV $208.50
- TVGN N/A
- Revenue Next Year
- NEOV $128.75
- TVGN N/A
- P/E Ratio
- NEOV N/A
- TVGN N/A
- Revenue Growth
- NEOV 52.64
- TVGN N/A
- 52 Week Low
- NEOV $1.80
- TVGN $0.26
- 52 Week High
- NEOV $6.11
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- NEOV 74.78
- TVGN 49.84
- Support Level
- NEOV $3.10
- TVGN $1.19
- Resistance Level
- NEOV $3.57
- TVGN $1.27
- Average True Range (ATR)
- NEOV 0.35
- TVGN 0.05
- MACD
- NEOV 0.14
- TVGN -0.00
- Stochastic Oscillator
- NEOV 89.18
- TVGN 57.14
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.